Medtronic PLC vs Peloton Interactive Inc — how do they compare? Medtronic PLC trades at $88.46 (market cap $112.24B), while Peloton Interactive Inc trades at $5.07 (market cap $2.16B). The key difference: Medtronic PLC is far larger — about 52× Peloton Interactive Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Peloton Interactive Inc for 37 Days on average.
| MDT | PTON | |
|---|---|---|
Market Cap | $112.24B | $2.16B |
Volume | 105,663,236 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $7.86 |
52-Week Low | $73.75 | $3.71 |
Typical Hold Time | 63 Days | 37 Days |
Enterprise Value | $131.58B | $2.66B |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Peloton (PTON) trades at $5.06, up 4.33% on the day, but remains in a bearish technical trend. The company reported its first full-year net profit in fiscal 2026, with Q2 2026 EPS beating expectations at $0.13 versus $0.12, though revenue declined to $2.49B in 2025. Recent news highlights the launch of a new, more affordable Tread Flex treadmill and AI-powered coaching features as part of its turnaround strategy. Analyst consensus is a 'Buy' with a $8.00 price target, but negative shareholder equity and high debt levels pose significant risks.
The outlook is mixed; cost-cutting and new product launches support a path to sustained profitability, but subscriber declines, high leverage, and insider selling temper optimism. The stock offers speculative upside if execution improves, yet remains vulnerable to competitive pressures and macroeconomic headwinds. Investors should weigh the potential for operational turnaround against persistent financial and business model challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →